Quetiapine fumarate and Entresto drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Quetiapine fumarate (quetiapine fumarate) and Entresto (sacubitril; valsartan). Common drug interactions include angina pectoris among females and angina pectoris among males.
The phase IV clinical study analyzes what interactions people have when they take Quetiapine fumarate and Entresto. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.
What is Quetiapine fumarate?
Quetiapine fumarate has active ingredients of quetiapine fumarate. It is often used in insomnia. eHealthMe is studying from 29,525 Quetiapine fumarate users. Check the latest studies of Quetiapine fumarate.
What is Entresto?
Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,623 Entresto users. Check the latest studies of Entresto.
64 people who take Quetiapine fumarate and Entresto together, and have interactions are studied.
What are the common drug interactions of Quetiapine fumarate and Entresto, by gender? *
What are the common drug interactions of Quetiapine fumarate and Entresto, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Quetiapine fumarate and Entresto?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Quetiapine fumarate (29,525 reports)
- Entresto (126,623 reports)
Browse all drug interactions of Quetiapine fumarate and Entresto:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Quetiapine fumarate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Entresto:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Quetiapine fumarate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Entresto and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
- Shah Z, Londhe V, "Influence of various media on the dissolution profiles of immediate-release quetiapine tablets in India", Dissolution Technologies, 2016 Feb .
- Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
- Shah Z, Londhe V, "Influence of various media on the dissolution profiles of immediate-release quetiapine tablets in India", Dissolution Technologies, 2016 Feb .
How the study uses the data?
The study uses data from the FDA. It is based on quetiapine fumarate and sacubitril; valsartan (the active ingredients of Quetiapine fumarate and Entresto, respectively), and Quetiapine fumarate and Entresto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Torsemide and Plasmacytoma Of Bone for Women aged 60+ - 5 seconds ago
- Torsemide and Plasma Cell Myeloma for Women aged 60+ - 5 seconds ago
- Torsemide and Plasma Cell Dyscrasia for Women aged 60+ - 5 seconds ago
- Torsemide and Myeloma - Multiple for Women aged 60+ - 5 seconds ago
- Torsemide and Malignant Plasmacytoma for Women aged 60+ - 6 seconds ago
- Torsemide and Multiple Myeloma for Women aged 60+ - 6 seconds ago
- Drug interactions of Ceftin and Humira - 7 seconds ago
- Could Pravachol cause Sleep Disorder? - 7 seconds ago
- Olanzapine and Speech Disorder for Men aged 40-49 - 7 seconds ago
- Could Campath cause Hepatitis C? - 16 seconds ago